As chief of the Division of Pulmonary and Critical Care Medicine at the University of Virginia, I feel excited and privileged to be working with so many intelligent, talented, aspiring, and young physicians, nurse practitioners, care takers, scientists and staff.
The Division has a rich history and tradition of excellence in patient care, education and research. We currently have 23 faculty members (2 full professors, 3 associate professors, 15 assistant professors, 1 instructor, 1 full research professor, 1 associate research professor, 10 NPs) and 10 clinical pulmonary and critical care fellows. Our faculty members strive to provide the best possible care to patients with a variety of disorders, ranging from obstructive lung diseases in asthma and COPD, to pulmonary arterial hypertension, cystic fibrosis and the interstitial lung disease. We also provide the best possible care to the most critically ill patients in the medical intensive care unit. The lung transplant group has been increasing activity while maintaining some of the best outcomes in the nation. These activities allow the division to provide the best training environment for the next generation of physicians and scientists for discoveries in bench, translational and outcomes medicine.
The Division houses several clinical and research programs in Cystic Fibrosis recognized by the CF foundation, Sleep medicine, PAH in collaboration with cardiology, and COPD and ILD centers of excellence, drawing patients from far and wide. The ILD program houses expertise in genetics, genomics and clinical trials with participation in numerous industry and NIH sponsored trials. We also engage in cutting-edge bronchoscopic techniques for lung cancer screening and diagnosis. We are extending efforts with an Immune Checkpoint lung disease clinic, and increasing outreach in asthma and COPD.
Pulmonary and Critical Care Medicine Clinical Updates
The division continues to grow both in the ambulatory setting and in the critical care arena. The ambulatory practice operates in the primary care clinic, Fishersville, and Zion Crossroads. Beginning next academic year, in addition to our MICU, we will have a joint attending/nurse practitioner operated ICU at Culpeper as well. Last year we added several new faculty: Dr. Lindsey Somerville who graduated from our fellowship and whose clinical practice is now focused on CF, while advancing her lab investigations in Dr. Tom Braciale’s lab; Catherine Bonham, from the University of Chicago, whose clinical focus is in Sarcoidosis and ILD, while she continues her investigative efforts in immunobiology and ILD. While Dr. Timothy Scialla is expected to join the Division from Duke University as an Associate Professor, his clinical focus is asthma and COPD. Expansion continues with efforts to increase our presence in Sleep medicine and CF.
Currently, our division runs the MICU, a pulmonary consult service and consults at TCH. We also offer outpatient services at the Sleep lab/clinics and outpatient bronchoscopy and pulmonary specialty clinics.
Imre Noth, MD
Division Chief, Pulmonary & Critical Care Medicine
Filed Under: News and Notes
Tags: March 2019 Newsletter, Pulmonary